Title | Large conserved domains of low DNA methylation maintained by Dnmt3a. |
Publication Type | Journal Article |
Year of Publication | 2014 |
Authors | Jeong, M, Sun, D, Luo, M, Huang, Y, Challen, GA, Rodriguez, B, Zhang, X, Chavez, L, Wang, H, Hannah, R, Kim, S-B, Yang, L, Ko, M, Chen, R, Göttgens, B, Lee, J-S, Gunaratne, P, Godley, LA, Darlington, GJ, Rao, A, Li, W, Goodell, MA |
Journal | Nat Genet |
Volume | 46 |
Issue | 1 |
Pagination | 17-23 |
Date Published | 2014 Jan |
ISSN | 1546-1718 |
Keywords | Animals, Base Sequence, Conserved Sequence, CpG Islands, Cytosine, Databases, Genetic, DNA (Cytosine-5-)-Methyltransferase, DNA Methylation, Epigenesis, Genetic, Gene Expression Regulation, Hematopoietic Stem Cells, Histones, Humans, Leukemia, Male, Mice, Mice, Inbred C57BL, Mice, Mutant Strains |
Abstract | Gains and losses in DNA methylation are prominent features of mammalian cell types. To gain insight into the mechanisms that promote shifts in DNA methylation and contribute to changes in cell fate, including malignant transformation, we performed genome-wide mapping of 5-methylcytosine and 5-hydroxymethylcytosine in purified mouse hematopoietic stem cells. We discovered extended regions of low methylation (canyons) that span conserved domains frequently containing transcription factors and are distinct from CpG islands and shores. About half of the genes in these methylation canyons are coated with repressive histone marks, whereas the remainder are covered by activating histone marks and are highly expressed in hematopoietic stem cells (HSCs). Canyon borders are demarked by 5-hydroxymethylcytosine and become eroded in the absence of DNA methyltransferase 3a (Dnmt3a). Genes dysregulated in human leukemias are enriched for canyon-associated genes. The new epigenetic landscape we describe may provide a mechanism for the regulation of hematopoiesis and may contribute to leukemia development. |
DOI | 10.1038/ng.2836 |
Alternate Journal | Nat. Genet. |
PubMed ID | 24270360 |
PubMed Central ID | PMC3920905 |
Grant List | CA125123 / CA / NCI NIH HHS / United States K99 DK084259 / DK / NIDDK NIH HHS / United States R56 DK092883 / DK / NIDDK NIH HHS / United States AI07495 / AI / NIAID NIH HHS / United States DK092883 / DK / NIDDK NIH HHS / United States R01 HD065812 / HD / NICHD NIH HHS / United States AG036562 / AG / NIA NIH HHS / United States R01HG007538 / HG / NHGRI NIH HHS / United States DK084259 / DK / NIDDK NIH HHS / United States WT079249 / WT / WETP NIH HHS / United States T32 AI007495 / AI / NIAID NIH HHS / United States P50 CA126752 / CA / NCI NIH HHS / United States P30 CA125123 / CA / NCI NIH HHS / United States R01 CA151535 / CA / NCI NIH HHS / United States CA151535 / CA / NCI NIH HHS / United States CA126752 / CA / NCI NIH HHS / United States RC2 AG036562 / AG / NIA NIH HHS / United States WT100140 / WT / WETP NIH HHS / United States R01 HG007538 / HG / NHGRI NIH HHS / United States R00 DK084259 / DK / NIDDK NIH HHS / United States MRC_G0900951 / / Medical Research Council / United Kingdom R01 DK092883 / DK / NIDDK NIH HHS / United States |